AIG
XERS icon

American International Group’s Xeris Biopharma Holdings XERS Stock Holding History

American International Group’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-65,577
Closed -$145K – 2769
2024
Q1 		$145K Sell
65,577
-563
-0.9% -$1.46K ﹤0.01% 2320
2023
Q4 		$155K Sell
66,140
-267
-0.4% -$493 ﹤0.01% 2306
2023
Q3 		$124K Buy
66,407
+2,361
+4% +$5.41K ﹤0.01% 2392
2023
Q2 		$168K Buy
64,046
+146
+0.2% +$372 ﹤0.01% 2277
2023
Q1 		$104K Buy
63,900
+1,272
+2% +$1.59K ﹤0.01% 2433
2022
Q4 		$83.3K Sell
62,628
-228
-0.4% -$322 ﹤0.01% 2592
2022
Q3 		$98K Buy
62,856
+888
+1% +$1.47K ﹤0.01% 2570
2022
Q2 		$95K Buy
+61,968
New +$131K ﹤0.01% 2633
2021
Q2 		– Sell
-26,788
Closed -$121 – 3288
2021
Q1 		$121 Buy
26,788
+71
+0.3% +$383 ﹤0.01% 2618
2020
Q4 		$131 Sell
26,717
-767
-3% -$3.84K ﹤0.01% 2517
2020
Q3 		$163K Buy
27,484
+4,653
+20% +$18.6K ﹤0.01% 2264
2020
Q2 		$61K Buy
22,831
+1,741
+8% +$6.06K ﹤0.01% 2809
2020
Q1 		$41K Buy
21,090
+4,394
+26% +$18.9K ﹤0.01% 2763
2019
Q4 		$118K Sell
16,696
-142
-0.8% -$1.17K ﹤0.01% 2528
2019
Q3 		$166K Sell
16,838
-116
-0.7% -$1.3K ﹤0.01% 2298
2019
Q2 		$194K Buy
16,954
+3,896
+30% +$40.9K ﹤0.01% 2252
2019
Q1 		$131K Buy
13,058
+8,655
+197% +$111K ﹤0.01% 2465
2018
Q4 		$75K Buy
4,403
+13
+0.3% +$261 ﹤0.01% 2734
2018
Q3 		$77K Buy
+4,390
New +$95.3K ﹤0.01% 2946

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return

American International Group's XERS Position: Q2 2024 in Review

American International Group sold out of Xeris Biopharma Holdings (XERS) in Q2 2024, closing a stake of 65,577 shares — an estimated $145K sold.

American International Group first reported a position in XERS in Q3 2018 and held it in 19 quarters. The position peaked at $194K in Q2 2019. 134 funds tracked by Wall St. Rank hold XERS as of Q2 2024.

  • American International Group reported no remaining Xeris Biopharma Holdings position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 65,577 Xeris Biopharma Holdings shares in Q2 2024, an estimated $145K.
  • American International Group first reported a position in Xeris Biopharma Holdings in Q3 2018 and held it in 19 quarters.
  • American International Group's Xeris Biopharma Holdings position peaked at $194K in Q2 2019.
  • 134 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.